Australia
December 6, 2011
DIR 111 - Limited and controlled release of wheat and barley genetically modified for altered grain composition, nutrient utilisation efficiency, disease resistance or stress tolerance
INVITATION TO COMMENT
Consultation RARMP for licence application DIR 111 from the Commonwealth Scientific and Industrial Research Organisation: Limited and Controlled Release of Genetically Modified (GM) Wheat and Barley
Australia’s gene technology regulatory system is designed to protect the health and safety of people and the environment by identifying risks posed by, or as a result of, gene technology and managing those risks.
The Gene Technology Regulator is currently assessing Licence Application DIR 111 from the Commonwealth Scientific and Industrial Research Organisation (CSIRO) for a limited and controlled release of up to 292 lines of wheat and 41 lines of barley genetically modified for altered grain composition, nutrient utilisation efficiency, disease resistance or stress tolerance.
The purpose of the trial is to assess the agronomic performance and grain properties of the GM wheat and barley lines grown under field conditions. The trial is proposed to take place at one site in the Australian Capital Territory, on a maximum area of 2.3 ha per year, between May 2012 and June 2017. The GM wheat and barley will not be used in commercial human food or animal feed. However, products derived from the grain of a few GM wheat and barley lines with altered grain composition may be used for a range of carefully controlled small scale animal and human (GM wheat only) nutritional trials.
A consultation Risk Assessment and Risk Management Plan (RARMP) has been prepared, which concludes that the proposed release would pose negligible risk to human health and safety or to the environment. A range of licence conditions are proposed, including measures to restrict the release to the size, location and duration requested by CSIRO.
The Regulator welcomes written submissions in order to finalise the RARMP, which will then form the basis of a decision on whether or not to issue the licence. The consultation RARMP and related documents can be obtained from the website http://www.ogtr.gov.au under ‘What’s New’ or by contacting the Office. Please quote application DIR 111 in any correspondence.
Submissions should be received by close of business on 16 January 2012.
Office of the Gene Technology Regulator, MDP 54, GPO BOX 9848 CANBERRA ACT 2601
Telephone: 1800 181 030 Facsimile: 02 6271 4202 E-mail: ogtr@health.gov.au
DIR 111 - Invitation to comment on a consultation Risk Assessment and Risk Management Plan for the limited and controlled release of wheat and barley genetically modified for altered grain composition, nutrient utilisation efficiency, disease resistance or stress tolerance - comments close on 16 January 2012 - posted 5 December 2011
DIR 111 - Questions and Answers (PDF 91 KB)
DIR 111 - Consultation Risk Assessment and Risk Management Plan (RARMP) Executive Summary (PDF 217 KB)
DIR 111 - Consultation Risk Assessment and Risk Management Plan (RARMP) Technical Summary (PDF 195 KB)
DIR 111 - Full consultation Risk Assessment and Risk Management Plan (RARMP) for the limited and controlled release of wheat and barley genetically modified for altered grain composition, nutrient utilisation efficiency, disease resistance or stress tolerance (PDF 837 KB)
DIR 111 - Licence Application Summary (PDF 193 KB)
Reference material
Topics
Species
